Clinical Trial Update: Cisplatin and Fluorouracil Compared With Carboplatin and Paclitaxel in Treating Patients With Inoperable Locally Recurrent or Metastatic Anal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing cisplatin/fluorouracil versus carboplatin/paclitaxel in patients with inoperable locally recurrent or metastatic anal cancer; status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Canal Cancer
• Anal Cancer
• Anal Squamous Cell Carcinoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• CISPLATIN (cisplatin)
• FLUOROURACIL (Fluorouracil)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: ECOG-ACRIN Cancer Research Group | Conditions: Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma | Phase 2 | Status: UNKNOWN